Literature DB >> 12087338

Round window application of D-methionine provides complete cisplatin otoprotection.

Kurtis D Korver1, Leonard P Rybak, Craig Whitworth, Kathleen M Campbell.   

Abstract

OBJECTIVE: Cisplatin is a widely used, very effective chemotherapeutic agent that can cause severe ototoxicity. In this study, D-methionine was tested as an otoprotectant via round window membrane (RWM) application in the chinchilla.
METHODS: A minute amount of cisplatin alone, or D-methionine followed by cisplatin, was applied topically directly to the intact RWM of anesthetized adult chinchillas. Auditory brainstem responses were measured before and 1 week after topical round window application. Animals were killed, and the cochleas were examined.
RESULTS: The ears pretreated with D-methionine were completely protected from hearing loss and hair cell loss in the organ of Corti compared with controls. The ears receiving cisplatin without D-methionine protection sustained nearly complete hearing loss with threshold shifts of >60 dB, with extensive outer hair cell loss throughout the organ of Corti but particularly in the basal turn.
CONCLUSION: These results demonstrate that topical D-methionine provides excellent otoprotection against cisplatin-induced ototoxicity both electrophysiologically and structurally.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12087338     DOI: 10.1067/mhn.2002.125299

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  28 in total

1.  Therapy of hearing disorders - conservative procedures.

Authors:  Stefan Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

2.  The design and screening of drugs to prevent acquired sensorineural hearing loss.

Authors:  Debashree Mukherjea; Leonard P Rybak; Kelly E Sheehan; Tejbeer Kaur; Vickram Ramkumar; Sarvesh Jajoo; Sandeep Sheth
Journal:  Expert Opin Drug Discov       Date:  2011-03-15       Impact factor: 6.098

Review 3.  Local inner-ear drug delivery and pharmacokinetics.

Authors:  Alec N Salt; Stefan K R Plontke
Journal:  Drug Discov Today       Date:  2005-10-01       Impact factor: 7.851

Review 4.  Otoprotectants: From Research to Clinical Application.

Authors:  Colleen G Le Prell
Journal:  Semin Hear       Date:  2019-04-26

5.  Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity?

Authors:  Issam Saliba; Fouad El Fata
Journal:  Neurotox Res       Date:  2011-10-12       Impact factor: 3.911

Review 6.  Effect of intratympanic dimethyl sulphoxide (DMSO) in an in vivo model of cisplatin-related ototoxicity.

Authors:  A Roldán-Fidalgo; A Trinidad; A Rodríguez-Valiente; J R García-Berrocal; I Millán; M J Coronado; R Ramírez-Camacho
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-08       Impact factor: 2.503

7.  The Protective Effect of Chrysin Against Cisplatin İnduced Ototoxicity in Rats.

Authors:  Mehmet Kelles; Mehmet Tan; M Tayyar Kalcioglu; Yuksel Toplu; Nazire Bulam
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-11-28

8.  Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Tejbeer Kaur; Kelly E Sheehan; Vickram Ramkumar; Leonard P Rybak
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

9.  Transtympanic steroids in refractory sudden hearing loss. Personal experience.

Authors:  I Dallan; L Bruschini; A Nacci; B Fattorp; A C Traino; F Rognini; G Ferraro; P Bruschini
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-02       Impact factor: 2.124

10.  Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Craig Whitworth; Jennifer R Bunch; Jeremy G Turner; Leonard P Rybak; Vickram Ramkumar
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.